Drug Shortage Report for ONDANSETRON INJECTION, USP

Last updated on 2020-04-02 History
Report ID 105793
Drug Identification Number 02390051
Brand name ONDANSETRON INJECTION, USP
Common or Proper name ONDANSETRON INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML 1VL
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2020-03-31
Actual start date
Estimated end date 2020-05-12
Actual end date 2020-04-01
Shortage status Resolved
Updated date 2020-04-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-04-02 French Compare
v7 2020-04-02 English Compare
v6 2020-04-01 English Compare
v5 2020-03-05 French Compare
v4 2020-03-05 English Compare
v3 2020-02-29 English Compare
v2 2020-02-12 French Compare
v1 2020-02-12 English Compare

Showing 1 to 8 of 8